Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

122 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Subcutaneous sarilumab for the treatment of hospitalized patients with moderate to severe COVID19 disease: A pragmatic, embedded randomized clinical trial.
Branch-Elliman W, Ferguson R, Doros G, Woods P, Leatherman S, Strymish J, Datta R, Goswami R, Jankowich MD, Shah NR, Taylor TH, Page ST, Schiller SJ, Shannon C, Hau C, Flynn M, Holmberg E, Visnaw K, Dhond R, Brophy M, Monach PA. Branch-Elliman W, et al. PLoS One. 2022 Feb 25;17(2):e0263591. doi: 10.1371/journal.pone.0263591. eCollection 2022. PLoS One. 2022. PMID: 35213547 Free PMC article. Clinical Trial.
Coronavirus disease 2019 (COVID-19) hospitalization metrics that do not account for disease severity underestimate protection provided by severe acute respiratory coronavirus virus 2 (SARS-CoV-2) vaccination and boosting: A retrospective cohort study.
Corrigan JK, La J, Fillmore NR, Do NV, Brophy M, Doron S, Monach PA, Branch-Elliman W. Corrigan JK, et al. Infect Control Hosp Epidemiol. 2023 Jan;44(1):149-151. doi: 10.1017/ice.2022.79. Epub 2022 May 23. Infect Control Hosp Epidemiol. 2023. PMID: 35599374 Free PMC article. No abstract available.
Recent common human coronavirus infection protects against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection: A Veterans Affairs cohort study.
Fillmore NR, Szalat RE, La J, Branch-Elliman W, Monach PA, Nguyen V, Samur MK, Brophy MT, Do NV, Munshi NC. Fillmore NR, et al. Proc Natl Acad Sci U S A. 2022 Nov 16;119(46):e2213783119. doi: 10.1073/pnas.2213783119. Epub 2022 Nov 7. Proc Natl Acad Sci U S A. 2022. PMID: 36343242 Free PMC article. No abstract available.
Patient- reported reasons for non-participation in a COVID-19 therapeutics clinical trial: Findings from a multi-center investigation.
Dassum SR, Ferguson R, Woods P, Flynn M, Visnaw K, Holmberg E, Schiller S, Shannon C, Brophy M, Monach P, Leatherman S, Branch-Elliman W; VISN-1 Clinical Trials Network COVID-19 Investigators. Dassum SR, et al. Contemp Clin Trials. 2023 Mar;126:107082. doi: 10.1016/j.cct.2023.107082. Epub 2023 Jan 9. Contemp Clin Trials. 2023. PMID: 36632925 Free PMC article.
122 results